OBN Awards Nomination



MIP Diagnostics are proud to be shortlisted as finalists at the OBN Awards in October, in the “Bioseed One to watch category”.  

Dr John Harris, CEO of OBN (UK) said: “We received the highest number of qualifying entries for the OBN Awards this year, up a staggering 40% on last year’s total.

The standard of entries across all categories was extremely high and we are encouraged about the level of exciting new innovation and positive growth we are seeing in UK Life Sciences. We look forward to celebrating with all our finalists on 11 October at the Examination Schools in Oxford.” https://lnkd.in/eu_EkQh.